Advertisement.

CLVLF Projected Dividend Yield

Ord/Clinuvel Pharmaceuticals Ltd. ( OTCBB : CLVLF )

Clinuvel Pharmaceuticals is a biopharmaceutical company focussed on developing and delivering treatments for patients with a range of genetic and skin disorders. Co.'s research and development is focussed on treatments for patient populations with a clinical need for photoprotection and repigmentation. Co. is focused on developing and commercialising SCENESSE® as a preventative therapy to photo-protect patients with erythropoietic protoporphyria. Co. is also focused on developing and commercializing SCENESSE® as a combination therapy with narrowband ultraviolet B phototherapy for patients with vitiligo. Co. has operations in Europe, Singapore and the United States.

17 YEAR PERFORMANCE RESULTS

CLVLF Dividend History Detail
CLVLF Dividend News
CLVLF Competitors News

# of Shares: 0

Closing Price: 7.83

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2018	0.02	0%	0	$ 0.00	0.00%
2019	0.03	25%	0	$ 0.00	0.00%
2020	0.03	0%	0	$ 0.00	0.00%
2021	0.03	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.04	0%	0	$ 0.00	0.00%
2026	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend Amount (AUD)
2022	N/A	N/A	Sep 07, 2022	Sep 21, 2022	0.0400
2022 Total:					0.0400
2021	N/A	N/A	Sep 03, 2021	Sep 17, 2021	0.0250
2021 Total:					0.0250
2020	N/A	N/A	Sep 04, 2020	Sep 18, 2020	0.0250
2020 Total:					0.0250